Germany's BDS goes independent:
This article was originally published in Clinica
Executive Summary
BDS International Diagnostics has been spun off from its US-based parent company, Polymedco, through a management buy-out. The new company, located in Schwetzingen, Germany, specialises in helping in vitro diagnostics and medical device suppliers to establish a foothold in European markets. Its services include searching, screening, selecting, training and managing a network of 1,800 distributors, with 650 in Europe. It also helps with regulatory issues. "Many of our international clients find it easier to meet Eastern European distributors this way, as they are often unable to attend trade fairs," George Skinner, director of sales and marketing at BDS International Diagnostics, told Clinica.